Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations
Authors:
- Joo-Yong HahnJHJoo-Yong Hahn
- Seung-Hyuk ChoiSCSeung-Hyuk Choi
- Jin-Ho ChoiJCJin-Ho Choi
- Sang Hoon LeeSLSang Hoon Lee
- Myung-Ho JeongMJMyung-Ho Jeong
- Hyo-Soo KimHKHyo-Soo Kim
- In-Whan SeongISIn-Whan Seong
- Ju-Young YangJYJu-Young Yang
- Seung Woon RhaSRSeung Woon Rha
- Yangsoo JangYJYangsoo Jang
- Jung Han YoonJYJung Han Yoon
Abstract
No abstract availableKeywords
Funding Information
- Korean Society of Interventional Cardiology
This publication has 20 references indexed in Scilit:
- Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcationsAmerican Heart Journal, 2008
- Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting StentsJACC, 2007
- Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary PracticeJACC, 2007
- Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stentsAmerican Heart Journal, 2007
- Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery LesionsJAMA, 2006
- Una clasificación simple de las lesiones coronarias en bifurcaciónRevista Espanola de Cardiologia, 2006
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003